These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 15172931)

  • 1. Clinical implications of genetic polymorphism of CYP2D6 in Mexican Americans.
    Flores DL; Alvarado I; Wong ML; Licinio J; Flockhart D
    Ann Intern Med; 2004 Jun; 140(11):W71. PubMed ID: 15172931
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of CYP2D6 polymorphisms on dextromethorphan metabolism in Mexican Americans.
    Casner PR
    J Clin Pharmacol; 2005 Nov; 45(11):1230-5. PubMed ID: 16239355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of CYP2D6 impaired functional alleles in Mexican Americans.
    Luo HR; Gaedigk A; Aloumanis V; Wan YJ
    Eur J Clin Pharmacol; 2005 Dec; 61(11):797-802. PubMed ID: 16283274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adverse effects of switching from fluoxetine to desipramine.
    Van Ameringen M; Mancini C
    Can J Psychiatry; 1992 May; 37(4):278. PubMed ID: 1611591
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy.
    Max MB; Lynch SA; Muir J; Shoaf SE; Smoller B; Dubner R
    N Engl J Med; 1992 May; 326(19):1250-6. PubMed ID: 1560801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dangerous interaction with nefazodone added to fluoxetine, desipramine, venlafaxine, valproate and clonazepam combination therapy.
    Benazzi F
    J Psychopharmacol; 1997; 11(2):190-1. PubMed ID: 9208383
    [No Abstract]   [Full Text] [Related]  

  • 7. CYP2D6 polymorphism in a Mexican American population.
    Mendoza R; Wan YJ; Poland RE; Smith M; Zheng Y; Berman N; Lin KM
    Clin Pharmacol Ther; 2001 Dec; 70(6):552-60. PubMed ID: 11753272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tachycardia, orthostatic hypotension and profound weakness due to concomitant use of fluoxetine and nifedipine.
    Azaz-Livshits TL; Danenberg HD
    Pharmacopsychiatry; 1997 Nov; 30(6):274-5. PubMed ID: 9442553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of a corticotropin-releasing hormone receptor 1 haplotype and antidepressant treatment response in Mexican-Americans.
    Licinio J; O'Kirwan F; Irizarry K; Merriman B; Thakur S; Jepson R; Lake S; Tantisira KG; Weiss ST; Wong ML
    Mol Psychiatry; 2004 Dec; 9(12):1075-82. PubMed ID: 15365580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Managing rapid metabolizers of antidepressants.
    Kraus RP; Diaz P; McEachran A
    Depress Anxiety; 1996-1997; 4(6):320-7. PubMed ID: 9166660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluoxetine and desipramine in major depressive disorder.
    Bowden CL; Schatzberg AF; Rosenbaum A; Contreras SA; Samson JA; Dessain E; Sayler M
    J Clin Psychopharmacol; 1993 Oct; 13(5):305-11. PubMed ID: 8227488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Re: no evidence of increased adverse drug reactions in cytochrome P450 CYP2D6 poor metabolizers treated with fluoxetine or nortriptyline.
    Gillman PK
    Hum Psychopharmacol; 2005 Jan; 20(1):61-2; author reply 63-4. PubMed ID: 15614840
    [No Abstract]   [Full Text] [Related]  

  • 13. CYP2D6 ultrarapid metabolism and early dropout from fluoxetine or amitriptyline monotherapy treatment in major depressive patients.
    Peñas-Lledó EM; Trejo HD; Dorado P; Ortega A; Jung H; Alonso E; Naranjo ME; López-López M; Llerena A
    Mol Psychiatry; 2013 Jan; 18(1):8-9. PubMed ID: 22733128
    [No Abstract]   [Full Text] [Related]  

  • 14. A controlled trial of fluoxetine and desipramine in depressed women with advanced cancer.
    Holland JC; Romano SJ; Heiligenstein JH; Tepner RG; Wilson MG
    Psychooncology; 1998; 7(4):291-300. PubMed ID: 9741068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Can yohimbine be used to treat orthostatic hypotension associated with the use of desipramine and other antidepressants? What general and/or specific strategy do you recommend for treating orthostatic hypotension?
    Price LH; Heninger GR
    J Clin Psychopharmacol; 1988 Oct; 8(5):384. PubMed ID: 3183081
    [No Abstract]   [Full Text] [Related]  

  • 16. Novel CYP2D6 and CYP2C19 variants identified in a patient with adverse reactions towards venlafaxine monotherapy and dual therapy with nortriptyline and fluoxetine.
    Chua EW; Foulds J; Miller AL; Kennedy MA
    Pharmacogenet Genomics; 2013 Sep; 23(9):494-7. PubMed ID: 23799451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluoxetine induces elevation of desipramine level and exacerbation of geriatric nonpsychotic depression.
    Bell IR; Cole JO
    J Clin Psychopharmacol; 1988 Dec; 8(6):447-8. PubMed ID: 3266222
    [No Abstract]   [Full Text] [Related]  

  • 18. Clomipramine, fluoxetine and CYP2D6 metabolic capacity in depressed patients.
    Vandel P; Haffen E; Nezelof S; Broly F; Kantelip JP; Sechter D
    Hum Psychopharmacol; 2004 Jul; 19(5):293-8. PubMed ID: 15252821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medical complications of polydipsia in nonpsychotic depression.
    Benazzi F; Bartolini F; Mazzoli M
    Can J Psychiatry; 1994 Apr; 39(3):185. PubMed ID: 7518339
    [No Abstract]   [Full Text] [Related]  

  • 20. No evidence of increased adverse drug reactions in cytochrome P450 CYP2D6 poor metabolizers treated with fluoxetine or nortriptyline.
    Roberts RL; Mulder RT; Joyce PR; Luty SE; Kennedy MA
    Hum Psychopharmacol; 2004 Jan; 19(1):17-23. PubMed ID: 14716707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.